Skip to main content

Clinical Data Reorganizes Business Into Three Units

NEW YORK, March 1, (GenomeWeb News) - Clinical Data today said it has reorganized its business into three units: PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance. The unit is developing CNS, cardiovascular, and oncology tests, the company said.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark, and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.